RESUMO
Beta-l-2',3'-didehydro-2',3'-dideoxy-N(4)-hydroxycytidine (l-Hyd4C) was demonstrated to be an effective and highly selective inhibitor of hepatitis B virus (HBV) replication in HepG2.2.15 cells (50% effective dose [ED(50)] = 0.03 microM; 50% cytotoxic dose [CD(50)] = 2,500 microM). In the present study, we investigated the intracellular pharmacology of tritiated l-Hyd4C in HepG2 cells. l-[(3)H]Hyd4C was shown to be phosphorylated extensively and rapidly to the 5'-mono-, 5'-di-, and 5'-triphosphate derivatives. Other metabolites deriving from a reduction or removal of the NHOH group of l-Hyd4C could not be detected, although both reactions were described as the primary catabolic pathways of the stereoisomer ss-d-N(4)-hydroxycytidine in HepG2 cells. Also, the formation of liponucleotide metabolites, such as the 5'-diphosphocholine derivative of l-Hyd4C, as described for some l-deoxycytidine analogues, seems to be unlikely. After incubation of HepG2 cells with 10 microM l-[(3)H]Hyd4C for 24 h, the 5'-triphosphate accumulated to 19.4 +/- 2.7 pmol/10(6) cells. The predominant peak belonged to 5-diphosphate, with 43.5 +/- 4.3 pmol/10(6) cells. The intracellular half-life of the 5'-triphosphate was estimated to be 29.7 h. This extended half-life probably reflects a generally low affinity of 5'-phosphorylated l-deoxycytidine derivatives for phosphate-degrading enzymes but may additionally be caused by an efficient rephosphorylation of the 5'-diphosphate during a drug-free incubation. The high 5'-triphosphate level and its extended half-life in HepG2 cells are consistent with the potent antiviral activity of l-Hyd4C.
Assuntos
Antivirais/farmacologia , Vírus da Hepatite B/efeitos dos fármacos , Zalcitabina/análogos & derivados , Antivirais/metabolismo , Biotransformação , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Citidina Desaminase/farmacologia , Desoxicitidina/metabolismo , Meia-Vida , Humanos , Fígado/metabolismo , Fosforilação , Zalcitabina/metabolismo , Zalcitabina/farmacologiaRESUMO
Lymphocyte reactivity to 3-M KCl extracts from fetuses of different species of origin was shown by the macrophage electrophoretic mobility (MEMB) and/or the leukocyte migration inhibition tests in tumor-bearing mice and humans. In chemical carcinogenesis, reactivity was detectable before tumors developed. Six weeks after sc injection of 1,000 micrograms benzo[a]pyrene [(BP) CAS: 50-32-8] into XVII/Bln mice, the MEMB test became positive. The latent period was 15 weeks after 1.0 micrograms BP, indicating a dose-response relationship of the phenomenon. Painting of mouse skin with 7,12-dimethylbenz[a]anthracene [(DMBA) CAS: 57-97-6], croton oil (CAS: 8001-28-3), or benzene (CAS: 71-43-2) had the same sensitizing effect as BP. In contrast to the strong carcinogens BP and DMBA that caused lymphocyte reactivity to persist until tumors developed, benzene and the promoter croton oil induced only a transient effect. Termination of treatment abolished reactivity within 12 weeks. Lymphocyte reactivity to fetal extract in normal cell proliferation was evident from the fact that two-thirds-hepatectomized rats and BCG-treated mice became MEMB-positive. In hepatectomized rats the effect was reversible according to the completion of liver regeneration. Lymphocytes from tumor-bearing mice reacted with mouse and human fetal extract as well as with extracts from different developmental stages of frogs and fish. Fetal extracts were assumed to contain a phylogenetically conserved antigen.
Assuntos
Antígenos de Neoplasias/imunologia , Proteínas Fetais/imunologia , Linfócitos/imunologia , Neoplasias/imunologia , Lesões Pré-Cancerosas/imunologia , Animais , Antígenos de Neoplasias/isolamento & purificação , Divisão Celular , Linhagem Celular , Embrião de Galinha , Reações Cruzadas , Embrião de Mamíferos/imunologia , Embrião não Mamífero , Feminino , Proteínas Fetais/isolamento & purificação , Feto/imunologia , Peixes , Cobaias , Hepatectomia , Humanos , Imunidade Celular , Masculino , Camundongos , Transplante de Neoplasias , Neoplasias/induzido quimicamente , Filogenia , Lesões Pré-Cancerosas/induzido quimicamente , Gravidez , Ranidae , Ratos , SerpentesRESUMO
Drug targeting via lipoproteins may be of benefit for use of cytotoxic drugs like fluorothymidine (FLT) or azidothymidine (AZT). Both drugs are potent inhibitors of the human immunodeficiency virus (HIV) reverse transcriptase and are used in the therapy of HIV infection. With regard to this project, the selective endocytosis in HIV infected human macrophages was studied after covalent coupling of AZT and LDL to low density lipoproteins (LDL). Cultured human macrophages and the lymphocytic Molt 4/8 cell line were infected with HIV-1 in vitro and subsequently treated with FLT-LDL or AZT-LDL. Viral replication was followed by determination of cell-released capsid antigen p24. Internalisation into HIV-1 infected human macrophages by the scavenger receptor pathway leads to a dose dependent inhibition of HIV replication. Otherwise, in HIV infected, but scavenger receptor missing lymphocytes (Molt 4/8 cells), neither endocytosis nor inhibition of HIV replication results. Thus, covalent coupling of drugs to LDL leads to a macrophage specific transport. This strategy could possibly avoid toxic side effects in the therapeutic use of antiretroviral drugs and thus may open a way for an earlier chemotherapy in HIV infection.
Assuntos
Didesoxinucleosídeos/administração & dosagem , Infecções por HIV/tratamento farmacológico , Leucócitos Mononucleares/microbiologia , Receptores de LDL/metabolismo , Zidovudina/administração & dosagem , Células Cultivadas , Didesoxinucleosídeos/química , Endocitose , Transcriptase Reversa do HIV/antagonistas & inibidores , Humanos , Lipoproteínas LDL/metabolismo , Inibidores da Transcriptase Reversa/farmacologia , Replicação Viral/efeitos dos fármacos , Zidovudina/químicaRESUMO
In a previous paper, we determined that treatment of lymphocytes with nonviable preparations of human immunodeficiency virus type 1 (HIV-1) results in an impairment of the phosphatidylinositol/protein kinase C pathway, most likely due to an inhibition of the cleavage of phosphatidylinositol bisphosphate into inositol trisphosphate and diacylglycerol, mediated by phospholipase C. Here we show that one consequence of these changes is a reduced phosphorylation of nuclear matrix-associated DNA topoisomerase II, resulting in an inhibition of the activity of this enzyme. Antibodies to the viral proteins suppressed the inhibitory effects caused by the HIV-1 preparation. Furthermore, the phytohemagglutinin A-caused augmentation of nuclear matrix-associated DNA polymerase alpha and beta activities was found to be abolished by coincubation with the HIV preparation or with the HIV-1 gp120. The phytohemagglutinin A-enhanced matrix association and processivity of DNA polymerase alpha was determined to be reduced if the lymphocytes were in contact with HIV-1 preparation. These results suggest that the reduced proliferative response of lymphocytes to phytohemagglutinin A in the presence of disrupted HIV-1 preparation is due to inhibition of at least two, perhaps separate, pathways, one involving protein kinase C resulting in a reduced phosphorylation of DNA topoisomerase II and the other changing the state of matrix association of DNA polymerase alpha and beta.
Assuntos
DNA Polimerase II/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Proteína gp120 do Envelope de HIV , HIV-1 , Humanos , Técnicas In Vitro , Linfócitos/enzimologia , Matriz Nuclear/enzimologia , FosforilaçãoRESUMO
Novel beta-L-2',3'-dideoxy-3'-fluoro nucleosides were synthesized and further converted to their 5'-triphosphates. Their inhibitory activities against hepatitis B virus (HBV) and duck hepatitis B virus (DHBV) DNA polymerases, human immunodeficiency virus (HIV) reverse transcriptase (RT), and the cellular DNA polymerases alpha, beta, gamma, delta, and epsilon were investigated and compared with those of the corresponding 3'-fluoro-modified beta-d-analogues. The 5'-triphosphates of 3'-deoxy-3'-fluoro-beta-L-thymidine (beta-L-FTTP), 2',3'-dideoxy-3'-fluoro-beta-L-cytidine (beta-L-FdCTP), and 2',3'-dideoxy-3'-fluoro-beta-l-5-methylcytidine (beta-L-FMetdCTP) emerged as effective inhibitors of HBV/DHBV DNA polymerases (IC50 = 0.25-10.4 microM). They were either equally (FTTP) or less (FMetdCTP, FdCTP) effective than their beta-d-counterparts. Also the 5'-triphosphate of beta-L-thymidine (beta-L-TTP) was shown to be a strong inhibitor of these two viral enzymes (IC50 = 0.46/1.0 microM). However, all beta-L-FdNTPs (also beta-L-TTP) were inactive against HIV-RT, a result which contrasts sharply with the high efficiency of the beta-D- FdNTPs against this polymerase. Between the cellular DNA polymerases only the beta and gamma enzymes displayed a critical susceptibility to beta-D-FdNTPs which is largely abolished by the beta-L-enantiomers. These results recommend beta-L-FTdR, beta-L-FCdR, and beta-L-FMetCdR for further evaluation as selective inhibitors of HBV replication at the cellular level.
Assuntos
Inibidores Enzimáticos , Transcriptase Reversa do HIV/antagonistas & inibidores , Hepatite B/enzimologia , Inibidores da Síntese de Ácido Nucleico , Organofosfatos , Nucleosídeos de Pirimidina , Animais , Bovinos , DNA Polimerase I/antagonistas & inibidores , DNA Polimerase I/isolamento & purificação , DNA Polimerase II/antagonistas & inibidores , DNA Polimerase II/isolamento & purificação , DNA Polimerase III/antagonistas & inibidores , DNA Polimerase III/isolamento & purificação , DNA Polimerase beta/antagonistas & inibidores , DNA Polimerase beta/isolamento & purificação , DNA Polimerase gama , DNA Polimerase Dirigida por DNA/isolamento & purificação , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Transcriptase Reversa do HIV/isolamento & purificação , Células HeLa , Vírus da Hepatite B do Pato/enzimologia , Humanos , Cinética , Organofosfatos/síntese química , Organofosfatos/química , Organofosfatos/farmacologia , Placenta/enzimologia , Nucleosídeos de Pirimidina/síntese química , Nucleosídeos de Pirimidina/química , Nucleosídeos de Pirimidina/farmacologia , Inibidores da Transcriptase Reversa/síntese química , Inibidores da Transcriptase Reversa/química , Inibidores da Transcriptase Reversa/farmacologia , Estereoisomerismo , Relação Estrutura-AtividadeRESUMO
Infection of monocytes with human immunodeficiency virus type 1 (HIV-1) (strain Ada-M) caused increased levels of leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) in vitro. These two products result from the activities of the two enzymes cyclooxygenase and 5-lipoxygenase. The addition of the sesquiterpenoid hydroquinone Avarol, an HIV inhibitor, strongly reduced the levels of LTB4 and PGE2 via inhibition of both cyclooxygenase and lipoxygenase in monocytes. The 50% inhibition concentrations (IC50) for the enzymes were determined to be 2.26 microM (cyclooxygenase) and 1.97 microM (lipoxygenase). A 50% reduction of the extent of PGE2 and LTB4 production in HIV-infected monocytes was measured at a concentration of 0.9 microM Avarol, a dose which caused an 80% anti-HIV effect in vitro (50% inhibition of virus release from infected cells: 0.3 microM). We conclude that Avarol inhibits the enzymes cyclooxygenase and lipoxygenase and suggest that, in general, inhibitors of these enzymes are promising anti-HIV compounds.
Assuntos
Antivirais/farmacologia , Dinoprostona/metabolismo , HIV-1/fisiologia , Leucotrieno B4/metabolismo , Monócitos/microbiologia , Sesquiterpenos/farmacologia , Araquidonato 5-Lipoxigenase/metabolismo , Inibidores de Ciclo-Oxigenase/farmacologia , HIV-1/efeitos dos fármacos , Inibidores de Lipoxigenase/farmacologia , Monócitos/metabolismo , Prostaglandina-Endoperóxido Sintases/metabolismoRESUMO
The superhelical properties of chromosomal DNA from cells of a mouse sarcoma were investigated in neutral sucrose gradients containing ethidium bromide. Removal of negative supercoiling from the DNA of the sarcoma cells required a substantially higher dye concentration than was necessary in the case of DNA from cultured mouse fibroblasts. The calculated value of the mean superhelical density in malignant cells (sigma = -0.14) appears abnormally high compared with the value (sigma = -0.09) obtained for DNA of mouse fibroblasts. Chromosomal DNA from mouse sarcoma cells is therefore concluded to be highly deficient in helical turns.
Assuntos
Cromossomos/análise , DNA de Neoplasias/análise , Sarcoma Experimental/análise , Animais , Nucléolo Celular/análise , Centrifugação com Gradiente de Concentração , Etídio/farmacologia , Camundongos , Camundongos EndogâmicosRESUMO
In view of clinical trials to improve FUra chemotherapy of cancer by combined application with Urd and dThd, we investigated the capacity of human tissues to split these nucleosides. All human normal and neoplastic tissues gave a uridine-splitting activity which can be inhibited by beta-L-pTdR and behaves in this respect as uridine-deoxyuridine phosphorylase (EC 2.4.2.3). dThd splitting, however, which is 2-9-fold higher than that of Urd, is insensitive towards beta-L-pTdR, confirming earlier results that it is due to thymidine phosphorylase (EC 2.4.2.4). On the other hand, tissues, e.g., spleen of rats and mice, in which dThd and Urd are split by uridine-deoxyuridine phosphorylase, degrade 2-5-fold more Urd than dThd. Thus, free pyrimidine base competing with FUra for degradation and thus prolonging the life time of the drug in the body, will be formed mainly from dThd in the human body but more so from Urd in the rat or mouse.
Assuntos
Fluoruracila/uso terapêutico , Timidina/metabolismo , Uridina/metabolismo , Animais , Desoxiuridina/farmacologia , Humanos , Técnicas In Vitro , Fígado/metabolismo , Camundongos , Modelos Biológicos , Pentosiltransferases/metabolismo , Pirimidina Fosforilases , Ratos , Baço/metabolismo , Distribuição TecidualRESUMO
The effect of analogues of both 2',3'-dideoxy-3'-fluorothymidine (FddThd) [2',3'-dideoxy-3'-fluorouridine (FddUrd), 2',3'-dideoxy-3'-fluoro-5-chlorouridine (FddClUrd), 2',3'-dideoxy-3'- fluoro-5-bromouridine (FddBrUrd) and 2',3'-dideoxy-3'-fluoro-5-bromovinyluridine (FddBVUrd)] and 2',3'-dideoxy-3'-fluorocytidine (FddCyt) [2',3'-dideoxy-3'-fluoro-5-fluorocytidine (FddFCyt), 2',3'-dideoxy-3'-fluoro-5-chlorocytidine (FddClCyt), 2',3'-dideoxy-3'-fluoro-5-methylcytidine (FddMeCyt), 2',3'-dideoxy-3'-fluoro-5-ethylcytidine (FddEtCyt), 2',3'-dideoxy-3'-chloro-5-methylcytidine (ClddMeCyt), 2',3'-dideoxy-3'-amino-5-methylcytidine (AmddMeCyt), 2',3'-dideoxy-3'-azido-5- methylcytidine (AzddMeCyt) and arabinosyl-5-methylcytosine (AraMeCyt)] were tested for their potential antiviral activity in vitro using the human hepatoblastoma cell line, Hep G2 2.2.15, which was transfected with a vector containing hepatitis B virus (HBV). It was found that FddThd, FddMeCyt, FddEtCyt, ClddMeCyt, AmddMeCyt and AraMeCyt display cytostatic activity at concentrations (CD50 values) between 0.54 (FddMeCyt) and 3.93 microM (FddEtCyt), while FddUrd, FddClUrd, FddBrUrd, FddBVUrd, FddCyt, FddFCyt, FddClCyt and AzddMeCyt do not affect cell growth at concentrations of up to 25 microM. Among the thymidine analogues tested, FddThd is the most effective antiviral agent: at a concentration of 0.03 microM a more than 90% reduction of HBV DNA synthesis was measured. On the other hand, the antiviral indexes displayed by FddClUrd, FddBrUrd and FddBVUrd are higher than tht of FddThd; FddUrd was completely inactive. The most powerful antiviral agents in the group of cytidine analogues tested in vitro were FddMeCyt (more than 90% reduction of HBVDNA synthesis at 0.10 microM) and ClddMeCyt (0.10 microM); FddClCyt, FddEtCyt, AmddMeCyt and AraMeCyt were of intermediate activity. None of the negligible antiviral activity was determined for FddUrd, FddCyt, FddFCyt and AzddMeCyt. FddThd and FddMeCyt displayed in vivo an antiviral effect in the duck/duck HBV (DHBV) animal system. Administration of 10 or 20 mg/kg (total daily dose) of FddThd and 5 or 10 mg/kg of FddMeCyt (i.m. daily) to ducks infected with DHBV for 12 days blocked virus production. Termination of treatment with FddThd of infected animals led to reappearance of the virus in the serum though at lower levels. The in vitro and the in vivo data suggest that FddThd and FddMeCyt might be promising antiviral agents for the treatment of infection caused by HBV in humans.
Assuntos
Desoxicitidina/análogos & derivados , Didesoxinucleosídeos/farmacologia , Vírus da Hepatite B/efeitos dos fármacos , Zalcitabina/análogos & derivados , Animais , Antígenos Virais/análise , DNA Viral/análise , DNA Viral/sangue , Desoxicitidina/farmacologia , Relação Dose-Resposta a Droga , Patos/microbiologia , Humanos , Transfecção , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/microbiologia , Replicação Viral/efeitos dos fármacos , Zalcitabina/farmacologiaRESUMO
Antiviral effects of nucleoside analogues against human adenoviruses (ADV) belonging to subgroup B (ADV3) and C (ADV2) were comparatively analysed using focus reduction assay on Fogh and Lund (FL) cells. 3'-Fluoro-2'-deoxythymidine (FTdR), 3'-fluoro-2'-deoxyuridine (FUdR), 2',3'-dideoxycytidine (ddC) and 3'-fluoro-2'-deoxyguanosine (FGdR) emerged as potent and selective inhibitors. They were nontoxic for the FL cells at the tested doses. FTdR was proved to be the most effective inhibitor against both serotypes ADV2 and ADV3 (0.05 microM/0.02 microM). The inhibitory effect of FTdR was also analyzed on the level of viral proteins and viral DNA synthesis using radioimmunoprecipitation and PCR, respectively. Neither the main structural protein of ADV, the hexon, nor viral DNA could be detected in ADV-infected FL cells that had been exposed to FTdR.
Assuntos
Adenovírus Humanos/efeitos dos fármacos , Antivirais/farmacologia , Didesoxinucleosídeos/farmacologia , Adenovírus Humanos/genética , Adenovírus Humanos/fisiologia , Antivirais/química , Sequência de Bases , Linhagem Celular , Primers do DNA/genética , DNA Viral/biossíntese , DNA Viral/genética , Desoxiguanosina/análogos & derivados , Desoxiguanosina/farmacologia , Didesoxinucleosídeos/química , Avaliação Pré-Clínica de Medicamentos , Floxuridina/farmacologia , Humanos , Reação em Cadeia da Polimerase , Replicação Viral/efeitos dos fármacos , Zalcitabina/farmacologiaRESUMO
Infection of H9 cells with human immunodeficiency virus type 1 (HIV-1) was found to decrease the phosphorylation of DNA topoisomerase II during the initial phase of infection. Simultaneously, with a later overshoot of phosphorylation and the subsequent activation of DNA topoisomerase II, the production of HIV-1 started. Applying three new protein kinase C inhibitors from the class of O-alkylglycerophospholipids we demonstrated that inhibition of protein kinase C-mediated phosphorylation of DNA topoisomerase II resulted in an inhibition of HIV-1 production. Based on the differential effect of the two protein kinase C activators, phorbol ester and bryostatin, we conclude that phosphorylation of DNA topoisomerase II is mediated by the form alpha and gamma of protein kinase C. These data suggest that agents which inhibit these two forms of protein kinase C are also potential candidates for an anti-HIV therapy.
Assuntos
DNA Topoisomerases Tipo I/metabolismo , HIV-1/crescimento & desenvolvimento , Animais , Briostatinas , Linhagem Celular , Eletroforese em Gel de Poliacrilamida , HIV-1/efeitos dos fármacos , Técnicas In Vitro , Lactonas/farmacologia , Lisofosfatidilcolinas/farmacologia , Macrolídeos , Fosforilação , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Ratos , Ratos Endogâmicos , Linfócitos T/enzimologia , Acetato de Tetradecanoilforbol/farmacologiaRESUMO
A method for screening of antiviral compounds against adenoviruses was established. Test compounds were diluted and plated in chamber slides for tissue culture. Drug-treated, virus-infected cultures were stained with fluorescein isothiocyanate conjugated rabbit antibodies against adenovirus hexon type 2 and fluorescent cells were counted by microscopy. This assay is more sensitive than the colorimetric method and requires smaller volumes of compounds when compared with the standard method using plaque assay.
Assuntos
Adenovírus Humanos/efeitos dos fármacos , Antivirais/farmacologia , Linhagem Celular , Avaliação Pré-Clínica de Medicamentos , Fluoresceína-5-Isotiocianato/química , HumanosRESUMO
Two novel enzyme-linked immunoassays (ELISA) for the quantitation of human immunodeficiency virus type 1 (HIV-1) coded glycoprotein with an Mr 120 (gp120) are described. These are based on the highly specific interaction between gp120 and the mannose-specific lectins from Narcissus pseudonarcissus (NPL) and Galanthus nivalis (GNL). Two systems were developed: (1) an HIV-protein ELISA using HIV-protein (also containing HIV-gp120) for the solid phase and NPL as a detector and (2) a lectin-ELISA using the NPL bound to the solid phase and GNL as detector. The HIV-protein ELISA was validated for quantitation of gp120 within the range 3 to 600 ng/ml; the lectin-ELISA for concentrations between 0.6 and 20000 ng gp120/ml. Serum components did not interfere with the binding of gp120 to the lectins. The ELISAs were used for the quantitation of gp120 in HIV-infected CEM cells in vitro. It was found that gp120 appeared in the medium earlier after infection than HIV-p24 and reverse transcriptase, suggesting that gp120 is released as free glycoprotein. Moreover, the ELISAs were also applied successfully for the detection of compounds that bind to gp120 and for the identification of antibodies directed against the highly pathogenic mannan portion of gp120. These ELISAs are considered to be suitable also for the detection of gp120 in the serum of HIV-infected individuals.
Assuntos
Ensaio de Imunoadsorção Enzimática/métodos , Proteína gp120 do Envelope de HIV/sangue , HIV-1 , Animais , Calibragem , Carboidratos/imunologia , Linhagem Celular , Galanthus , Giardia/metabolismo , Proteína gp120 do Envelope de HIV/imunologia , HIV-1/metabolismo , Humanos , Lectinas/metabolismo , Lectinas de Plantas , Sensibilidade e EspecificidadeRESUMO
Human T-lymphocytes can be transformed to unlimited growth by Herpesvirus saimiri (HVS). We studied the telomerase activity of a recently established HVS immortalized human CD4 T cell clone in comparison to peripheral blood lymphocytes (PBL) and unstimulated or phytohemagglutinin (PHA)-stimulated CD4 T-cells by a Telomeric Repeat Amplification-Protocol (TRAP) -Assay. Telomerase activity in PHA-stimulated CD4 T-cells was seven-fold and in HVS-infected CD4 T-cells 14-fold higher than in untreated CD4 T-cells. The HVS immortalized T-cell clone provides a useful tool for studying the regulation of telomerase activity during carcinogenesis and for testing of telomerase-inhibitory drugs.
Assuntos
Linfócitos T CD4-Positivos/enzimologia , Transformação Celular Viral/fisiologia , Herpesvirus Saimiriíneo 2/fisiologia , Telomerase/metabolismo , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/virologia , Células HL-60/citologia , Células HL-60/enzimologia , Humanos , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/enzimologia , Regulação para CimaRESUMO
We used purified bovine leukaemia virus (BLV) to test the inhibitory effects of suramin, HPA-23, and 3'-azidothymidine triphosphate (N3dTTP) on the reverse transcriptase activity. The 50% inhibitory concentrations (ID50) of the compounds were determined to be 2.8 mumol/l (suramin), 8.0 mumol/l (HPA-23), and 0.17 mumol/l (N3dTTP). Kinetic analyses of suramin and HPA-23 inhibition are discussed. The observed inhibitory effects emphasize the suitability of BLV as a model virus for investigations of retrovirus chemotherapy.
Assuntos
Antimônio/farmacologia , Antivirais/farmacologia , Vírus da Leucemia Bovina/efeitos dos fármacos , Retroviridae/efeitos dos fármacos , Inibidores da Transcriptase Reversa , Suramina/farmacologia , Compostos de Tungstênio , Tungstênio/farmacologia , Zidovudina/farmacologia , Animais , Bovinos , Cinética , Vírus da Leucemia Bovina/enzimologia , Modelos Biológicos , DNA Polimerase Dirigida por RNA/metabolismo , Suramina/farmacocinéticaAssuntos
Antivirais/farmacologia , Linhagem Celular/efeitos dos fármacos , Didesoxinucleosídeos/farmacologia , HIV/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Zalcitabina/farmacologia , Zidovudina/farmacologia , Divisão Celular/efeitos dos fármacos , Linhagem Celular/citologia , Didesoxinucleosídeos/metabolismo , HIV/fisiologia , Humanos , Replicação Viral/fisiologia , Zalcitabina/metabolismo , Zidovudina/metabolismoRESUMO
Novel N(4)-hydroxy- and 5-methyl-modified beta-L-deoxycytidine analogues were synthesized and evaluated as anti-hepatitis B virus (HBV) agents. Their in vitro efficiencies were investigated in HepG2.2.15 cells stably transfected with HBV. beta-L-2',3'-Didehydro-2',3'-dideoxy-N(4)-hydroxycytidine (beta-L-Hyd4C) was most effective in reducing secreted HBV DNA (50% effective concentration [EC(50)], 0.03 microM), followed by beta-L-2',3'-dideoxy-3'-thia-N(4)-hydroxycytidine (EC(50), 0.51 microM), beta-L-2',3'-dideoxy-N(4)-hydroxycytidine (EC(50), 0.55 microM), and beta-L-5-methyl-2'-deoxycytidine (EC(50), 0.9 microM). The inhibition of the presumed target, the HBV DNA polymerase, by the triphosphates of some of the beta-L-cytidine derivatives was also assessed. In accordance with the cell culture data, beta-L-Hyd4C triphosphate was the most active inhibitor, with a 50% inhibitory concentration of 0.21 microM. The cytotoxicities of some of the 4-NHOH-modified beta-L-nucleosides were dramatically lower than those of the corresponding cytidine analogues with the unmodified 4-NH(2) group. The 50% cytotoxic concentrations for beta-L-Hyd4C in HepG2 and HL-60 cells were 2,500 microM and 3,500 microM, respectively. In summary, our results demonstrate that at least beta-L-Hyd4C can be recommended as a highly efficient and extremely selective inhibitor of HBV replication for further investigations.
Assuntos
Antivirais/farmacologia , Desoxicitidina/análogos & derivados , Desoxicitidina/farmacologia , Vírus da Hepatite B/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Antivirais/síntese química , Antivirais/química , Antivirais/toxicidade , Carcinoma Hepatocelular/metabolismo , Linhagem Celular Tumoral , Desoxicitidina/metabolismo , Desoxicitidina/toxicidade , Relação Dose-Resposta a Droga , Células HL-60 , Vírus da Hepatite B/fisiologia , Humanos , Concentração Inibidora 50 , Neoplasias Hepáticas/metabolismo , Estrutura Molecular , Inibidores da Síntese de Ácido Nucleico , Fatores de Tempo , TransfecçãoRESUMO
Human telomerase is a ribonucleoprotein which uses its internal RNA moiety as a template for telomeric DNA synthesis. This enzyme is up-regulated in most malignant tumors and is therefore considered as a possible cancer target. Here we examined the effects of differently modified oligomers on telomeraseactivity from HL-60 cell extracts (TRAP-ezetrade mark assay). Phosphorothioate-modified oligonucleotides (PS-ODNs) inhibited telomerase activity at subnanomolar concen-trations and proved to be more efficient than peptide nucleic acids. In contrast to all the investigated oligomers, PS-ODNs were found to bind to the protein motif of telomerase called the primer binding site but poorly to its RNA. This is suggested by kinetic investigations demonstrating a competitive interaction of PS-ODNs and TS primer at the primer binding site. The K m value of the TS primer was 10.8 nM, the K i value of a 20mer PS-ODN was 1.6 nM. When the TS primer was PS-modified a striking increase in the telomerase activity was found which correlates with the number of phosphodiesters replaced. The K m value of a completely PS-modified TS primer was 0.56 nM. Based on these results the design of chimeric ODNs is proposed consisting of a 5'-PS-modified part targeting the primer binding site and a 3'-terminus part targeting the telomerase RNA.
Assuntos
Oligodesoxirribonucleotídeos Antissenso/metabolismo , Telomerase/genética , Telomerase/metabolismo , Tionucleotídeos/metabolismo , Ligação Competitiva , Primers do DNA , Células HL-60 , Humanos , RNA , Relação Estrutura-Atividade , Células Tumorais CultivadasRESUMO
Smears from 210 removed IUD's were taken in order to investigate them on actinomycetes. In 20 cases (9.5%) agglomeration of filaments and spores of actinomyces were found. All patients were free of complaints. During the control curettage carried out later on only in one of the cases actinomyces were found in the endometrium. Signs of serious inflammation couldn't be proved. In cases without any complaints no clinical consequences are to be followed after having found actinomyces on the removed IUD.
Assuntos
Actinomyces/isolamento & purificação , Actinomicose/transmissão , Técnicas Bacteriológicas , Dispositivos Intrauterinos/efeitos adversos , Adulto , Endometrite/microbiologia , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Risco , Cervicite Uterina/microbiologiaRESUMO
Of a series of 14 nucleoside 5'-triphosphates, those of 2',3'-dideoxy-3'-fluoro-5-methylcytidine, 3'-azido-2',3'-dideoxy-5-methylcytidine, 2',3'-dideoxy-3'-fluoroguanosine, 2',3'-didehydro-2',3'-dideoxy-5-methylcytidine, 2',3'-dideoxy-3'-fluoro-5-ethylcytidine, and 2',3'-dideoxy-3'-fluoroadenosine emerged as the most potent inhibitors of hepatitis B virus DNA polymerase (50% inhibitory dose, 0.03 to 0.35 microM). In contrast, cellular DNA polymerases proved to be resistant to (alpha) or partially affected by (beta) these analogs. These compounds are among the most effective and selective inhibitors of endogenous hepatitis B virus DNA polymerase recognized to date.